We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
-13.88%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$171M
AUM Growth
-$11.5M
Cap. Flow
+$18.1M
Cap. Flow %
10.58%
Top 10 Hldgs %
20.39%
Holding
661
New
479
Increased
74
Reduced
98
Closed
2

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$374K
2
ZIM icon
ZIM Integrated Shipping Services
ZIM
+$261K
3
FRG
Franchise Group, Inc.
FRG
+$244K
4
ILPT
Industrial Logistics Properties Trust
ILPT
+$240K
5
CWH icon
Camping World
CWH
+$229K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$512K
2
PLAN
Anaplan, Inc.
PLAN
+$472K
3
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$377K
4
ELV icon
Elevance Health
ELV
+$140K
5
IVZ icon
Invesco
IVZ
+$139K

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Real Estate 15.35%
3 Healthcare 12.51%
4 Industrials 11.52%
5 Consumer Staples 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSHA icon
626
Taysha Gene Therapies
TSHA
$1.85B
$1K ﹤0.01%
+380
New +$1.51K
TSVT
627
DELISTED
2seventy bio
TSVT
$1K ﹤0.01%
+43
New +$586
VOO icon
628
Vanguard S&P 500 ETF
VOO
$1.03T
$1K ﹤0.01%
+2
New +$753
WAB icon
629
Wabtec
WAB
$49.5B
$1K ﹤0.01%
+11
New +$980
WOW
630
DELISTED
WideOpenWest
WOW
$1K ﹤0.01%
+35
New +$703
YOLO icon
631
AdvisorShares Pure Cannabis ETF
YOLO
$31.3M
$1K ﹤0.01%
+225
New +$1.69K
CSCI
632
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$1K ﹤0.01%
+29
New +$726
TCON
633
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$1K ﹤0.01%
+16
New +$619
FUSN
634
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1K ﹤0.01%
+335
New +$1.54K
MDC
635
DELISTED
M.D.C. Holdings, Inc.
MDC
$1K ﹤0.01%
+27
New +$966
WTER
636
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$1K ﹤0.01%
+100
New +$867
XM
637
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$1K ﹤0.01%
+40
New +$712
ARC
638
DELISTED
ARC Document Solutions, Inc.
ARC
$1K ﹤0.01%
+500
New +$1.63K
ABEO icon
639
Abeona Therapeutics
ABEO
$416M
$0 ﹤0.01%
+55
New +$278
ACCO icon
640
Acco Brands
ACCO
$401M
$0 ﹤0.01%
+23
New +$168
AKBA icon
641
Akebia Therapeutics
AKBA
$236M
$0 ﹤0.01%
+900
New +$378
APVO icon
642
Aptevo Therapeutics
APVO
$5.11M
– –
0
– –
ARDX icon
643
Ardelyx
ARDX
$972M
$0 ﹤0.01%
+767
New +$565
ATNM icon
644
Actinium Pharmaceuticals
ATNM
$24.5M
$0 ﹤0.01%
+60
New +$341
CSTE icon
645
Caesarstone
CSTE
$87.1M
$0 ﹤0.01%
+29
New +$277
DTM icon
646
DT Midstream
DTM
$13.7B
$0 ﹤0.01%
+5
New +$273
DWAS icon
647
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$446M
$0 ﹤0.01%
+4
New +$313
GNLN icon
648
Greenlane Holdings
GNLN
$1.23M
– –
0
– –
HOOD icon
649
Robinhood
HOOD
$85.2B
$0 ﹤0.01%
+20
New +$195
KTB icon
650
Kontoor Brands
KTB
$4.26B
$0 ﹤0.01%
+6
New +$233
23 24 25
26
27

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Truvestments Capital held 661 positions worth $171M, down 6.3% from $182M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Truvestments Capital deployed $18.1M of net new capital in Q2 2022, opening 479 new positions and adding to 74 existing holdings. Its largest new stake was Warner Bros: 20,166 shares worth $271K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Real Estate and Healthcare.

On the sell side, the largest reduction was AT&T, an estimated $512K trimmed.

  • Truvestments Capital's largest Q2 2022 buy was Warner Bros: 20,166 shares worth $271K.
  • Truvestments Capital added most to ZIM Integrated Shipping Services in Q2 2022, an estimated $261K increase.
  • Truvestments Capital's biggest Q2 2022 reduction was AT&T, cutting an estimated $512K.
  • Truvestments Capital fully exited Anaplan, Inc. in Q2 2022, selling an estimated $472K.
  • Truvestments Capital's ten largest holdings make up 20% of its $171M portfolio in Q2 2022.
  • Truvestments Capital opened 479 new positions and closed 2 in Q2 2022.
  • Truvestments Capital's portfolio value fell 6.3% quarter-over-quarter to $171M.

Based on Truvestments Capital's 13F filing for Q2 2022, filed 9 Aug 2022.